Evolent Health, Inc.
EVH
$4.13
-$0.03-0.72%
NYSE
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 5.87% | -2.26% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.87% | -2.26% | |||
| Cost of Revenue | 11.04% | -2.18% | |||
| Gross Profit | -13.86% | -2.53% | |||
| SG&A Expenses | 16.97% | -18.07% | |||
| Depreciation & Amortization | -52.14% | 90.71% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.86% | -0.11% | |||
| Operating Income | -5.16% | -1,565.05% | |||
| Income Before Tax | 94.03% | -2,058.57% | |||
| Income Tax Expenses | 154.26% | -285.10% | |||
| Earnings from Continuing Operations | 93.79% | -1,956.80% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 93.79% | -1,956.80% | |||
| EBIT | -5.16% | -1,565.05% | |||
| EBITDA | -81.08% | 59.04% | |||
| EPS Basic | 93.81% | -1,528.46% | |||
| Normalized Basic EPS | 10.98% | -97.88% | |||
| EPS Diluted | 93.81% | -1,528.46% | |||
| Normalized Diluted EPS | 10.98% | -97.88% | |||
| Average Basic Shares Outstanding | 0.26% | -2.15% | |||
| Average Diluted Shares Outstanding | 0.26% | -2.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | 1.00% | |||